PCN312 - HOW HAS THE RELAUNCHED CANCER DRUGS FUND AFFECTED NICE’S APPROVAL OF NOVEL ONCOLOGY TECHNOLOGIES?
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.394
https://www.valueinhealthjournal.com/article/S1098-3015(18)33694-5/fulltext
Title :
PCN312 - HOW HAS THE RELAUNCHED CANCER DRUGS FUND AFFECTED NICE’S APPROVAL OF NOVEL ONCOLOGY TECHNOLOGIES?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33694-5&doi=10.1016/j.jval.2018.09.394
First page :
Section Title :
Open access? :
No
Section Order :
2297